Ameliorative Effect of Tirzepatide on Obesity-Induced Salivary Gland Injury in a Rat Model: Associated with Antioxidant, Anti-Inflammatory, Anti-Apoptotic, and Anti-Fibrotic Effects

Metabolic disorders from a high-fat diet impair salivary gland integrity, and the effect of tirzepatide on these glands is unknown. We investigated tirzepatide’s effects on high-fat diet (HFD)-induced salivary gland injury in rats. Forty adult male rats were randomly assigned to four groups: control (G1), HFD-fed (G2), HFD + saline (G3), and HFD + tirzepatide (G4). We assessed metabolic parameters, oxidative stress markers, inflammatory cytokines (TNF-α, IL-1β), caspase-3 concentration, stimulated salivary flow rate (SSFR), histopathology, and mast cell morphometry. HFD feeding caused insulin resistance and dyslipidemia, increased oxidative stress, TNF-α, IL-1β, and caspase-3 in salivary gland homogenate, histological damage to salivary gland tissue, increased mast cell indices, and collagen deposition. Tirzepatide significantly improved metabolic abnormalities and attenuated oxidative stress and inflammation, reduced caspase-3, mast cell, and fibrotic changes, and preserved salivary gland structure. SSFR showed no significant differences in pairwise comparisons. HFD-fed groups (G2 and G3) showed a reduced stimulated salivary rate per 100 g body weight (mL/15 min/100 g BW) compared with the control (G1). The tirzepatide-treated group (G4) had an improved stimulated salivary rate per 100 g BW, with no significant difference from the control (G1). The data suggest that tirzepatide ameliorates HFD-induced salivary gland injury, and this effect was associated with reduced oxidative stress, inflammatory cytokine levels (TNF-α, IL-1β), and caspase-3. The preservation of absolute SSFR despite marked tissue damage suggests that structural damage may occur without a concomitant reduction in overall stimulated salivary secretion.

Authors

Institutions

Publication Details

Journal
Life
Published
2026-11-20
DOI
https://doi.org/10.3390/life16111968
Primary Topic
Salivary Gland Disorders and Functions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Ameliorative Effect of Tirzepatide on Obesity-Induced Salivary Gland Injury in a Rat Model: Associated with Antioxidant, Anti-Inflammatory, Anti-Apoptotic, and Anti-Fibrotic Effects

Enas N. Morgan, Ayman Mousa
4 links
Life
Salivary Gland Disorders and Functions
article

Ameliorative Effect of Tirzepatide on Obesity-Induced Salivary Gland Injury in a Rat Model: Associated with Antioxidant, Anti-Inflammatory, Anti-Apoptotic, and Anti-Fibrotic Effects

Enas N. Morgan, Ayman Mousa
article en

Abstract

Metabolic disorders from a high-fat diet impair salivary gland integrity, and the effect of tirzepatide on these glands is unknown. We investigated tirzepatide’s effects on high-fat diet (HFD)-induced salivary gland injury in rats. Forty adult male rats were randomly assigned to four groups: control (G1), HFD-fed (G2), HFD + saline (G3), and HFD + tirzepatide (G4). We assessed metabolic parameters, oxidative stress markers, inflammatory cytokines (TNF-α, IL-1β), caspase-3 concentration, stimulated salivary flow rate (SSFR), histopathology, and mast cell morphometry. HFD feeding caused insulin resistance and dyslipidemia, increased oxidative stress, TNF-α, IL-1β, and caspase-3 in salivary gland homogenate, histological damage to salivary gland tissue, increased mast cell indices, and collagen deposition. Tirzepatide significantly improved metabolic abnormalities and attenuated oxidative stress and inflammation, reduced caspase-3, mast cell, and fibrotic changes, and preserved salivary gland structure. SSFR showed no significant differences in pairwise comparisons. HFD-fed groups (G2 and G3) showed a reduced stimulated salivary rate per 100 g body weight (mL/15 min/100 g BW) compared with the control (G1). The tirzepatide-treated group (G4) had an improved stimulated salivary rate per 100 g BW, with no significant difference from the control (G1). The data suggest that tirzepatide ameliorates HFD-induced salivary gland injury, and this effect was associated with reduced oxidative stress, inflammatory cytokine levels (TNF-α, IL-1β), and caspase-3. The preservation of absolute SSFR despite marked tissue damage suggests that structural damage may occur without a concomitant reduction in overall stimulated salivary secretion.

LifeVol. 16(11)
Qassim University (SA), Zagazig University (EG), Benha University (EG)
Good health and well-being
Salivary Gland Disorders and Functions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon